🇺🇸 FDA
Patent

US 6069283

Illudin analogs useful as antitumor agents

expired A61PA61P35/00A61P35/04

Quick answer

US patent 6069283 (Illudin analogs useful as antitumor agents) held by The Regents of the University of California expires Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 30 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P35/00, A61P35/04